 | Clinical Guidelines Resources |
Back to Resource Center Main
 |
Primary Care Management of Chronic Stable Angina and Asymptomatic Suspected or Known Coronary Artery Disease: A Clinical Practice Guideline from the American College of Physicians
The American College of Physicians–American Society of Internal Medicine, and the American College of Cardiology/American Heart Association (ACC/AHA) have developed these joint guidelines. They highlight information most likely to be important to primary car physicians. It covers the treatment and follow-up of symptomatic patients who have not had an acute myocardial infarction or revascularization procedure in the previous 6 months.
|
|
Management of Newly Detected Atrial Fibrillation: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians
The Joint Panel of the American Academy of Family Physicians and the American College of Physicians, in collaboration with the Johns Hopkins Evidence-based Practice Center, systematically reviewed the available evidence on the management of newly detected atrial fibrillation and developed recommendations for adult patients with first-detected atrial fibrillation. The target physician audience is internists and family physicians dedicated to primary care.
|
|
Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
These guidelines, were developed by the American Academy of Family Physicians and the American College of Physicians–American Society of Internal Medicine, with assistance from the American Headache Society. The target audience for this guideline is primary care physicians. The guideline applies to patients with acute migraine attacks, with or without aura, and patients with migraine who are candidates for preventive drug therapy
|
|
American College of Physicians–American Society of Internal Medicine: Pharmacologic Treatment of Acute Major Depression and Dysthymia
This guideline is based on an evidence report on pharmacotherapies for depression that was commissioned
by the Agency for Healthcare Research and Quality. It answers the following questions: What is the evidence supporting the benefits of pharmacologic treatment? What are the data on the efficacy and side effect profiles of “newer” compared with “older” pharmacotherapies? How can the evidence assist physicians and patients in making informed decisions about treatment options?
|
|
American College of Physicians.A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
The purpose of this paper is to help clinicians make informed choices about antidepressants and herbal therapies for the treatment of depression. This paper focuses on 29 newer antidepressants and 3 herbal remedies. Our goal was to summarize data on the efficacy of newer antidepressants and herbal treatments compared with placebo, older antidepressants, and each other for a broad spectrum of depressive disorders.
|
|
Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods
The CDC convened a panel of physicians representing the disciplines of internal medicine, family medicine, emergency medicine, and infectious diseases to develop principles provide evidence-based recommendations for evaluation and treatment of adults with acute respiratory illnesses. The goal of the principles is to provide clinicians with practical strategies for limiting antibiotic use to the patients who are most likely to benefit from it.
|
|
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
The goals of this paper are to review the literature to evaluate effects of management of hypertension on the complications of type 2 diabetes and, based on this literature, to determine optimal blood pressure goals and choice of agents. This will provide an evidence base to guide clinicians in setting hypertension treatment goals and priorities in patients with type 2 diabetes.
|
|
|
